# Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer

> **NCT02423226** · PHASE2 · COMPLETED · sponsor: **The First People's Hospital of Changzhou** · enrollment: 56 (actual)

## Conditions studied

- Rectum Cancer

## Interventions

- **PROCEDURE:** Computed tomography guided radioactive seeds implant
- **DRUG:** Systemic chemotherapy (FOLFIRI)

## Key facts

- **NCT ID:** NCT02423226
- **Lead sponsor:** The First People's Hospital of Changzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2014-12
- **Final completion:** 2015-04
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2015-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02423226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02423226, "Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02423226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*